B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis-Reference-Cited by-同舟云学术

B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis

Published:2021-09-28 Issue:11 Volume:73 Page:2086-2095
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Numajiri Hiroko¹,Kuzumi Ai¹,Fukasawa Takemichi¹,Ebata Satoshi¹^ORCID,Yoshizaki‐Ogawa Asako¹,Asano Yoshihide¹,Kazoe Yutaka²,Mawatari Kazuma¹,Kitamori Takehiko¹,Yoshizaki Ayumi¹^ORCID,Sato Shinichi¹

Affiliation:

1. University of Tokyo Graduate School of Medicine Tokyo Japan

2. Keio University School of Integrated Design Engineering Tokyo Japan

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41798

Reference49 articles.

1. Changes in causes of death in systemic sclerosis, 1972-2002

2. Abnormal B Lymphocyte Activation and Function in Systemic Sclerosis

3. Systemic sclerosis: New evidence re-enforces the role of B cells

4. Pathogenic roles of B lymphocytes in systemic sclerosis

5. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing autoimmune Rheumatic disease treatment: CAR-T Cell Therapies - Evidence, Safety, and future directions;Seminars in Arthritis and Rheumatism;2024-08

2. Deciphering autoantibody landscape of systemic sclerosis through systems-based approach: insights from a B-cell depletion clinical trial;2024-07-31

3. Research Progress in pathogenesis of connective tissue disease-associated interstitial lung disease from the perspective of pulmonary cells;Autoimmunity Reviews;2024-07

4. Sex differences in CXCL4‐mediated lung damage in the bleomycin‐induced systemic sclerosis mice model;Rheumatology & Autoimmunity;2024-06-28

5. Serum interleukin-34 levels in dermatomyositis: a potential biomarker for anti-MDA5-antibody-associated interstitial lung disease;Rheumatology;2024-06-03